nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—DRD4—conduct disorder	0.408	0.485	CbGaD
Amoxapine—SLC6A4—conduct disorder	0.245	0.291	CbGaD
Amoxapine—HTR2A—conduct disorder	0.188	0.224	CbGaD
Amoxapine—ORM1—saliva—conduct disorder	0.00724	0.204	CbGeAlD
Amoxapine—SLC6A2—autonomic nervous system—conduct disorder	0.00556	0.157	CbGeAlD
Amoxapine—HTR7—autonomic nervous system—conduct disorder	0.00536	0.151	CbGeAlD
Amoxapine—HTR2A—autonomic nervous system—conduct disorder	0.00334	0.0941	CbGeAlD
Amoxapine—DRD4—brain—conduct disorder	0.00165	0.0464	CbGeAlD
Amoxapine—DRD3—brain—conduct disorder	0.00116	0.0326	CbGeAlD
Amoxapine—HTR6—brain—conduct disorder	0.00111	0.0314	CbGeAlD
Amoxapine—Asenapine—DRD4—conduct disorder	0.000886	0.116	CrCbGaD
Amoxapine—DRD1—brain—conduct disorder	0.000829	0.0234	CbGeAlD
Amoxapine—HTR3A—brain—conduct disorder	0.000801	0.0226	CbGeAlD
Amoxapine—HTR1B—brain—conduct disorder	0.000672	0.0189	CbGeAlD
Amoxapine—GABRA1—brain—conduct disorder	0.000672	0.0189	CbGeAlD
Amoxapine—SLC6A3—brain—conduct disorder	0.000666	0.0188	CbGeAlD
Amoxapine—HTR2C—brain—conduct disorder	0.000644	0.0181	CbGeAlD
Amoxapine—SLC6A4—brain—conduct disorder	0.000611	0.0172	CbGeAlD
Amoxapine—Chlordiazepoxide—GABRA2—conduct disorder	0.00061	0.0797	CrCbGaD
Amoxapine—CHRM1—brain—conduct disorder	0.000608	0.0171	CbGeAlD
Amoxapine—HTR2B—brain—conduct disorder	0.000605	0.017	CbGeAlD
Amoxapine—HTR1A—brain—conduct disorder	0.000542	0.0153	CbGeAlD
Amoxapine—SLC6A2—brain—conduct disorder	0.000538	0.0151	CbGeAlD
Amoxapine—Asenapine—SLC6A4—conduct disorder	0.000532	0.0695	CrCbGaD
Amoxapine—HTR7—brain—conduct disorder	0.000518	0.0146	CbGeAlD
Amoxapine—Mazindol—SLC6A4—conduct disorder	0.00051	0.0666	CrCbGaD
Amoxapine—ADRA1A—brain—conduct disorder	0.0005	0.0141	CbGeAlD
Amoxapine—Olanzapine—DRD4—conduct disorder	0.000493	0.0644	CrCbGaD
Amoxapine—DRD2—brain—conduct disorder	0.00049	0.0138	CbGeAlD
Amoxapine—Estazolam—GABRA2—conduct disorder	0.000442	0.0578	CrCbGaD
Amoxapine—Fludiazepam—GABRA2—conduct disorder	0.000417	0.0545	CrCbGaD
Amoxapine—Asenapine—HTR2A—conduct disorder	0.000409	0.0534	CrCbGaD
Amoxapine—Prazepam—GABRA2—conduct disorder	0.000407	0.0532	CrCbGaD
Amoxapine—HRH1—brain—conduct disorder	0.000387	0.0109	CbGeAlD
Amoxapine—ADRA2A—brain—conduct disorder	0.00038	0.0107	CbGeAlD
Amoxapine—Oxazepam—GABRA2—conduct disorder	0.000367	0.048	CrCbGaD
Amoxapine—Temazepam—GABRA2—conduct disorder	0.000363	0.0474	CrCbGaD
Amoxapine—HTR2A—brain—conduct disorder	0.000323	0.0091	CbGeAlD
Amoxapine—Loxapine—DRD4—conduct disorder	0.000306	0.0401	CrCbGaD
Amoxapine—Diazepam—GABRA2—conduct disorder	0.000301	0.0394	CrCbGaD
Amoxapine—Quetiapine—DRD4—conduct disorder	0.000299	0.0391	CrCbGaD
Amoxapine—CYP2D6—brain—conduct disorder	0.000294	0.00829	CbGeAlD
Amoxapine—Clozapine—DRD4—conduct disorder	0.000257	0.0336	CrCbGaD
Amoxapine—Zuclopenthixol—HTR2A—conduct disorder	0.000239	0.0312	CrCbGaD
Amoxapine—Olanzapine—HTR2A—conduct disorder	0.000227	0.0297	CrCbGaD
Amoxapine—Loxapine—SLC6A4—conduct disorder	0.000184	0.024	CrCbGaD
Amoxapine—Loxapine—HTR2A—conduct disorder	0.000141	0.0185	CrCbGaD
Amoxapine—Quetiapine—HTR2A—conduct disorder	0.000138	0.018	CrCbGaD
Amoxapine—Clozapine—HTR2A—conduct disorder	0.000119	0.0155	CrCbGaD
Amoxapine—GABRA1—Neuronal System—MAOA—conduct disorder	0.000102	0.000885	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—CGA—conduct disorder	0.000102	0.000882	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—CGA—conduct disorder	0.000102	0.000878	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—CGA—conduct disorder	0.000101	0.000877	CbGpPWpGaD
Amoxapine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000101	0.000874	CbGpPWpGaD
Amoxapine—HTR2B—GPCR ligand binding—DRD4—conduct disorder	0.000101	0.000874	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—CGA—conduct disorder	0.000101	0.000872	CbGpPWpGaD
Amoxapine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	9.89e-05	0.000854	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—CGA—conduct disorder	9.87e-05	0.000853	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—CGA—conduct disorder	9.71e-05	0.000839	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—CGA—conduct disorder	9.63e-05	0.000832	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—DRD4—conduct disorder	9.57e-05	0.000826	CbGpPWpGaD
Amoxapine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.54e-05	0.000824	CbGpPWpGaD
Amoxapine—DRD1—GPCR ligand binding—DRD4—conduct disorder	9.54e-05	0.000824	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—CGA—conduct disorder	9.5e-05	0.000821	CbGpPWpGaD
Amoxapine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.5e-05	0.000821	CbGpPWpGaD
Amoxapine—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.49e-05	0.00082	CbGpPWpGaD
Amoxapine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	9.46e-05	0.000817	CbGpPWpGaD
Amoxapine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	9.45e-05	0.000816	CbGpPWpGaD
Amoxapine—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.42e-05	0.000813	CbGpPWpGaD
Amoxapine—DRD3—GPCR ligand binding—DRD4—conduct disorder	9.42e-05	0.000813	CbGpPWpGaD
Amoxapine—SLC6A4—SIDS Susceptibility Pathways—EP300—conduct disorder	9.33e-05	0.000806	CbGpPWpGaD
Amoxapine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	9.31e-05	0.000804	CbGpPWpGaD
Amoxapine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	9.29e-05	0.000802	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—CGA—conduct disorder	9.27e-05	0.000801	CbGpPWpGaD
Amoxapine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	9.26e-05	0.0008	CbGpPWpGaD
Amoxapine—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.23e-05	0.000797	CbGpPWpGaD
Amoxapine—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	9.15e-05	0.000791	CbGpPWpGaD
Amoxapine—CHRM1—G alpha (q) signalling events—HTR2A—conduct disorder	9.12e-05	0.000788	CbGpPWpGaD
Amoxapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	9.12e-05	0.000787	CbGpPWpGaD
Amoxapine—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.08e-05	0.000785	CbGpPWpGaD
Amoxapine—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	8.98e-05	0.000776	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—CGA—conduct disorder	8.74e-05	0.000755	CbGpPWpGaD
Amoxapine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.67e-05	0.000749	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—CGA—conduct disorder	8.63e-05	0.000745	CbGpPWpGaD
Amoxapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	8.47e-05	0.000732	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—CGA—conduct disorder	8.28e-05	0.000715	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—CGA—conduct disorder	8.24e-05	0.000712	CbGpPWpGaD
Amoxapine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.21e-05	0.000709	CbGpPWpGaD
Amoxapine—HTR1A—GPCR ligand binding—DRD4—conduct disorder	8.21e-05	0.000709	CbGpPWpGaD
Amoxapine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	8.19e-05	0.000707	CbGpPWpGaD
Amoxapine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.18e-05	0.000706	CbGpPWpGaD
Amoxapine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.16e-05	0.000705	CbGpPWpGaD
Amoxapine—HTR2C—GPCR ligand binding—DRD4—conduct disorder	8.16e-05	0.000705	CbGpPWpGaD
Amoxapine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	8.16e-05	0.000705	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—WASF1—conduct disorder	8.09e-05	0.000699	CbGpPWpGaD
Amoxapine—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.07e-05	0.000697	CbGpPWpGaD
Amoxapine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	8.03e-05	0.000694	CbGpPWpGaD
Amoxapine—SLC6A4—Circadian rythm related genes—EP300—conduct disorder	7.62e-05	0.000658	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—CGA—conduct disorder	7.52e-05	0.00065	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—CGA—conduct disorder	7.48e-05	0.000646	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—CGA—conduct disorder	7.27e-05	0.000628	CbGpPWpGaD
Amoxapine—HTR6—GPCR ligand binding—HTR2A—conduct disorder	7.23e-05	0.000625	CbGpPWpGaD
Amoxapine—HTR7—GPCR ligand binding—HTR2A—conduct disorder	7.23e-05	0.000624	CbGpPWpGaD
Amoxapine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.21e-05	0.000622	CbGpPWpGaD
Amoxapine—DRD2—GPCR ligand binding—DRD4—conduct disorder	7.21e-05	0.000622	CbGpPWpGaD
Amoxapine—CYP2D6—Biological oxidations—COMT—conduct disorder	7.18e-05	0.00062	CbGpPWpGaD
Amoxapine—HTR7—Circadian rythm related genes—EP300—conduct disorder	7.16e-05	0.000619	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	7.15e-05	0.000618	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—CGA—conduct disorder	7.14e-05	0.000617	CbGpPWpGaD
Amoxapine—CYP2D6—Biological oxidations—MAOA—conduct disorder	7.13e-05	0.000616	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—CGA—conduct disorder	7.12e-05	0.000615	CbGpPWpGaD
Amoxapine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	7.09e-05	0.000612	CbGpPWpGaD
Amoxapine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	7.08e-05	0.000612	CbGpPWpGaD
Amoxapine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.07e-05	0.000611	CbGpPWpGaD
Amoxapine—HRH1—GPCR ligand binding—DRD4—conduct disorder	7.07e-05	0.000611	CbGpPWpGaD
Amoxapine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.05e-05	0.000609	CbGpPWpGaD
Amoxapine—CHRM1—GPCR ligand binding—DRD4—conduct disorder	7.05e-05	0.000609	CbGpPWpGaD
Amoxapine—GABRA1—SIDS Susceptibility Pathways—EP300—conduct disorder	7.05e-05	0.000609	CbGpPWpGaD
Amoxapine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.03e-05	0.000607	CbGpPWpGaD
Amoxapine—HTR1B—GPCR ligand binding—HTR2A—conduct disorder	7.03e-05	0.000607	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	7e-05	0.000605	CbGpPWpGaD
Amoxapine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.99e-05	0.000604	CbGpPWpGaD
Amoxapine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	6.94e-05	0.0006	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	6.94e-05	0.0006	CbGpPWpGaD
Amoxapine—DRD4—GPCR ligand binding—HTR2A—conduct disorder	6.92e-05	0.000597	CbGpPWpGaD
Amoxapine—HRH4—GPCR downstream signaling—HTR2A—conduct disorder	6.87e-05	0.000594	CbGpPWpGaD
Amoxapine—DRD4—Circadian rythm related genes—EP300—conduct disorder	6.86e-05	0.000592	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—CGA—conduct disorder	6.6e-05	0.00057	CbGpPWpGaD
Amoxapine—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	6.6e-05	0.00057	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	6.51e-05	0.000562	CbGpPWpGaD
Amoxapine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	6.5e-05	0.000562	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—CGA—conduct disorder	6.5e-05	0.000561	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—CGA—conduct disorder	6.48e-05	0.00056	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—CGA—conduct disorder	6.46e-05	0.000558	CbGpPWpGaD
Amoxapine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	6.45e-05	0.000557	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	6.45e-05	0.000557	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	6.36e-05	0.00055	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—DRD4—conduct disorder	6.26e-05	0.000541	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—DRD4—conduct disorder	6.26e-05	0.000541	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—HTR2A—conduct disorder	6.24e-05	0.000539	CbGpPWpGaD
Amoxapine—DRD1—GPCR ligand binding—HTR2A—conduct disorder	6.23e-05	0.000538	CbGpPWpGaD
Amoxapine—DRD1—Circadian rythm related genes—EP300—conduct disorder	6.17e-05	0.000533	CbGpPWpGaD
Amoxapine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.17e-05	0.000533	CbGpPWpGaD
Amoxapine—DRD3—GPCR ligand binding—HTR2A—conduct disorder	6.14e-05	0.000531	CbGpPWpGaD
Amoxapine—DRD3—Circadian rythm related genes—EP300—conduct disorder	6.09e-05	0.000526	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—DRD4—conduct disorder	6.09e-05	0.000526	CbGpPWpGaD
Amoxapine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.06e-05	0.000524	CbGpPWpGaD
Amoxapine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.04e-05	0.000522	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CGA—conduct disorder	6e-05	0.000518	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CGA—conduct disorder	5.99e-05	0.000518	CbGpPWpGaD
Amoxapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	5.95e-05	0.000514	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	5.91e-05	0.000511	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CGA—conduct disorder	5.83e-05	0.000504	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CGA—conduct disorder	5.74e-05	0.000496	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	5.72e-05	0.000494	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—DRD4—conduct disorder	5.69e-05	0.000491	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—DRD4—conduct disorder	5.68e-05	0.000491	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—DRD4—conduct disorder	5.65e-05	0.000488	CbGpPWpGaD
Amoxapine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	5.62e-05	0.000485	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—DRD4—conduct disorder	5.53e-05	0.000478	CbGpPWpGaD
Amoxapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	5.53e-05	0.000477	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CGA—conduct disorder	5.48e-05	0.000473	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—DRD4—conduct disorder	5.39e-05	0.000466	CbGpPWpGaD
Amoxapine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	5.35e-05	0.000463	CbGpPWpGaD
Amoxapine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	5.33e-05	0.00046	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—DRD4—conduct disorder	5.32e-05	0.00046	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—DRD4—conduct disorder	5.19e-05	0.000449	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CGA—conduct disorder	5.17e-05	0.000446	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CGA—conduct disorder	5.1e-05	0.00044	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—DRD4—conduct disorder	4.9e-05	0.000423	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—DRD4—conduct disorder	4.83e-05	0.000417	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—WASF1—conduct disorder	4.81e-05	0.000415	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—WASF1—conduct disorder	4.8e-05	0.000415	CbGpPWpGaD
Amoxapine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	4.7e-05	0.000406	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—WASF1—conduct disorder	4.67e-05	0.000404	CbGpPWpGaD
Amoxapine—DRD2—Circadian rythm related genes—EP300—conduct disorder	4.66e-05	0.000403	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	4.64e-05	0.000401	CbGpPWpGaD
Amoxapine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	4.62e-05	0.000399	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	4.61e-05	0.000399	CbGpPWpGaD
Amoxapine—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	4.6e-05	0.000397	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—WASF1—conduct disorder	4.6e-05	0.000397	CbGpPWpGaD
Amoxapine—CHRM1—Circadian rythm related genes—EP300—conduct disorder	4.56e-05	0.000394	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	4.53e-05	0.000391	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CGA—conduct disorder	4.44e-05	0.000384	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CGA—conduct disorder	4.42e-05	0.000382	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—WASF1—conduct disorder	4.39e-05	0.000379	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	4.21e-05	0.000364	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	4.21e-05	0.000364	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	4.19e-05	0.000362	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—CGA—conduct disorder	4.18e-05	0.000361	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—WASF1—conduct disorder	4.14e-05	0.000358	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	4.09e-05	0.000353	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—WASF1—conduct disorder	4.09e-05	0.000353	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	4.08e-05	0.000353	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	4.07e-05	0.000352	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	4.01e-05	0.000346	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	4e-05	0.000345	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	3.98e-05	0.000344	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	3.97e-05	0.000343	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	3.92e-05	0.000339	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	3.91e-05	0.000338	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CGA—conduct disorder	3.9e-05	0.000337	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CGA—conduct disorder	3.84e-05	0.000332	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CGA—conduct disorder	3.83e-05	0.000331	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CGA—conduct disorder	3.82e-05	0.00033	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CGA—conduct disorder	3.76e-05	0.000325	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	3.73e-05	0.000322	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—HTR2A—conduct disorder	3.71e-05	0.000321	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—HTR2A—conduct disorder	3.71e-05	0.00032	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—DRD4—conduct disorder	3.7e-05	0.000319	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—HTR2A—conduct disorder	3.69e-05	0.000319	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	3.64e-05	0.000315	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	3.64e-05	0.000314	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—DRD4—conduct disorder	3.63e-05	0.000314	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—DRD4—conduct disorder	3.62e-05	0.000313	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	3.61e-05	0.000312	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	3.56e-05	0.000308	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—WASF1—conduct disorder	3.56e-05	0.000308	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—HTR2A—conduct disorder	3.55e-05	0.000307	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—WASF1—conduct disorder	3.54e-05	0.000306	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	3.52e-05	0.000304	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CGA—conduct disorder	3.49e-05	0.000302	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	3.47e-05	0.0003	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	3.39e-05	0.000293	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—DRD4—conduct disorder	3.36e-05	0.00029	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—DRD4—conduct disorder	3.36e-05	0.00029	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	3.31e-05	0.000286	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—DRD4—conduct disorder	3.27e-05	0.000282	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—HTR2A—conduct disorder	3.2e-05	0.000276	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—HTR2A—conduct disorder	3.15e-05	0.000272	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—WASF1—conduct disorder	3.13e-05	0.00027	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—WASF1—conduct disorder	3.08e-05	0.000266	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—WASF1—conduct disorder	3.07e-05	0.000265	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—DRD4—conduct disorder	3.07e-05	0.000265	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—WASF1—conduct disorder	3.06e-05	0.000264	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	3.03e-05	0.000261	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	3.01e-05	0.00026	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	3.01e-05	0.00026	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—DRD4—conduct disorder	2.89e-05	0.00025	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—DRD4—conduct disorder	2.85e-05	0.000247	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	2.8e-05	0.000242	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	2.75e-05	0.000237	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	2.73e-05	0.000236	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CGA—conduct disorder	2.72e-05	0.000235	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	2.66e-05	0.000229	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	2.61e-05	0.000225	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	2.6e-05	0.000225	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	2.56e-05	0.000221	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—DRD4—conduct disorder	2.49e-05	0.000215	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—DRD4—conduct disorder	2.47e-05	0.000214	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	2.41e-05	0.000208	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	2.38e-05	0.000205	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	2.37e-05	0.000205	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	2.36e-05	0.000204	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	2.32e-05	0.000201	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—HTR2A—conduct disorder	2.19e-05	0.000189	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—HTR2A—conduct disorder	2.19e-05	0.000189	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—DRD4—conduct disorder	2.18e-05	0.000189	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	2.16e-05	0.000187	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.15e-05	0.000186	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—DRD4—conduct disorder	2.14e-05	0.000185	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—DRD4—conduct disorder	2.14e-05	0.000185	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—HTR2A—conduct disorder	2.13e-05	0.000184	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	2.1e-05	0.000182	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—HTR2A—conduct disorder	2.1e-05	0.000181	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—HTR2A—conduct disorder	2e-05	0.000173	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—EP300—conduct disorder	1.99e-05	0.000172	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	1.96e-05	0.000169	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—EP300—conduct disorder	1.95e-05	0.000169	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—HTR2A—conduct disorder	1.89e-05	0.000163	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—COMT—conduct disorder	1.88e-05	0.000163	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—MAOA—conduct disorder	1.87e-05	0.000162	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—HTR2A—conduct disorder	1.86e-05	0.000161	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	1.62e-05	0.00014	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	1.61e-05	0.000139	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.43e-05	0.000123	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.4e-05	0.000121	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HTR2A—conduct disorder	1.39e-05	0.00012	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.37e-05	0.000119	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.28e-05	0.00011	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—COMT—conduct disorder	1.23e-05	0.000106	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—MAOA—conduct disorder	1.22e-05	0.000105	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—EP300—conduct disorder	1.16e-05	0.0001	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—EP300—conduct disorder	1.16e-05	0.0001	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—EP300—conduct disorder	1.13e-05	9.75e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—EP300—conduct disorder	1.11e-05	9.6e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—EP300—conduct disorder	1.06e-05	9.16e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—EP300—conduct disorder	1e-05	8.64e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—EP300—conduct disorder	9.87e-06	8.52e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EP300—conduct disorder	8.6e-06	7.43e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EP300—conduct disorder	8.56e-06	7.39e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—EP300—conduct disorder	8.08e-06	6.98e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EP300—conduct disorder	7.55e-06	6.52e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EP300—conduct disorder	7.43e-06	6.42e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EP300—conduct disorder	7.41e-06	6.4e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EP300—conduct disorder	7.39e-06	6.38e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EP300—conduct disorder	7.27e-06	6.28e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EP300—conduct disorder	6.76e-06	5.84e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—EP300—conduct disorder	5.27e-06	4.55e-05	CbGpPWpGaD
